Las células natural killer y su papel en la respuesta inmunitaria durante la infección por el virus de la inmunodeficiencia humana tipo-1

Carrega, 2012, Natural killer cell distribution and trafficking in human tissues, Front Immunol, 3, 347, 10.3389/fimmu.2012.00347 Vivier, 2008, Functions of natural killer cells, Nat Immunol, 9, 503, 10.1038/ni1582 Mamessier, 2013, Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets, J Immunol, 190, 2424, 10.4049/jimmunol.1200140 Sips, 2012, Altered distribution of mucosal NK cells during HIV infection, Mucosal Immunol, 5, 30, 10.1038/mi.2011.40 Higai, 2011, Binding affinities of NKG2D and CD94 to sialyl Lewis X-expressing N-glycans and heparin, Biol Pharm Bull, 34, 8, 10.1248/bpb.34.8 Laperrousaz, 2012, HLA and non-HLA polymorphisms in renal transplantation, Swiss Med Wkly, 142, w13668 Cooper, 2001, The biology of human natural killer-cell subsets, Trends Immunol, 22, 633, 10.1016/S1471-4906(01)02060-9 Jost, 2012, Evasion from NK cell-mediated immune responses by HIV-1, Microbes Infect, 14, 904, 10.1016/j.micinf.2012.05.001 Kramer, 2012, Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis, Hepatology, 56, 1201, 10.1002/hep.25804 Poli, 2009, CD56bright natural killer (NK) cells: An important NK cell subset, Immunology, 126, 458, 10.1111/j.1365-2567.2008.03027.x Moretta, 2006, Effector and regulatory events during natural killer-dendritic cell interactions, Immunol Rev, 214, 219, 10.1111/j.1600-065X.2006.00450.x Melki, 2010, Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk —a pivotal role of HMGB1, PLoS Pathog, 6, e1000862, 10.1371/journal.ppat.1000862 Carrington, 2012, Innate immune control of HIV, Cold Spring Harb Perspect Med, 2, a007070, 10.1101/cshperspect.a007070 Bell, 2002, Complex killing, Nat Rev Immunol, 2, 301, 10.1038/nri807 Fauriat, 2010, Regulation of human NK-cell cytokine and chemokine production by target cell recognition, Blood, 115, 2167, 10.1182/blood-2009-08-238469 Brenchley, 2006, HIV disease: Fallout from a mucosal catastrophe?, Nat Immunol, 7, 235, 10.1038/ni1316 Montoya, 2006, Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals, Clin Immunol, 120, 138, 10.1016/j.clim.2006.02.008 Walker, 2007, Elite control of HIV infection: Implications for vaccines and treatment, Top HIV Med, 15, 134 Reitano, 2009, Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection, AIDS Res Hum Retroviruses, 25, 1029, 10.1089/aid.2008.0311 Wong, 2010, Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults, AIDS Res Hum Retroviruses, 26, 459, 10.1089/aid.2009.0176 Brunetta, 2010, Pathologic natural killer cell subset redistribution in HIV-1 infection: New insights in pathophysiology and clinical outcomes, J Leukoc Biol, 88, 1119, 10.1189/jlb.0410225 Mavilio, 2005, Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals, Proc Natl Acad Sci U S A, 102, 2886, 10.1073/pnas.0409872102 Valentin-Torres, 2012, Bidirectional NK/DC interactions promote CD4 expression on NK cells DC maturation, and HIV infection, Virology, 433, 203, 10.1016/j.virol.2012.06.023 Fogli, 2004, Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients, Eur J Immunol, 34, 2313, 10.1002/eji.200425251 Leeansyah, 2010, Decreased NK cell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: A cross sectional study, PLoS One, 5, e9643, 10.1371/journal.pone.0009643 Lichtfuss, 2012, Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation, J Immunol, 189, 1491, 10.4049/jimmunol.1200458 Schwartz, 1996, Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein, Nat Med, 2, 338, 10.1038/nm0396-338 Ravet, 2007, Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals, Blood, 109, 4296, 10.1182/blood-2006-08-040238 Vieillard, 2005, NK cytotoxicity against CD4+ N.K cells during HIV-1 infection: A gp41 peptide induces the expression of an NKp44 ligand, Proc Natl Acad Sci USA, 102, 10981, 10.1073/pnas.0504315102 Parsons, 2012, HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity, J Virol, 86, 4488, 10.1128/JVI.06112-11 Fauci, 2005, NK cells in HIV infection: Paradigm for protection or targets for ambush, Nat Rev Immunol, 5, 835, 10.1038/nri1711 Migueles, 2001, Frequency and function of HIV-specific CD8(+) T cells, Immunol Lett, 79, 141, 10.1016/S0165-2478(01)00276-0 Marthas, 2011, Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques, Vaccine, 29, 3124, 10.1016/j.vaccine.2011.02.051 Jennes, 2006, Cutting edge: Resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands, J Immunol, 177, 6588, 10.4049/jimmunol.177.10.6588 Jia, 2013, Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression, Clin Exp Immunol, 171, 107, 10.1111/j.1365-2249.2012.04672.x Martin, 2002, Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS, Nat Genet, 31, 429, 10.1038/ng934 Carr, 2007, Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation, J Immunol, 178, 647, 10.4049/jimmunol.178.2.647 Tomescu, 2012, Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers, AIDS, 26, 1869, 10.1097/QAD.0b013e32835861b0 Kamya, 2011, Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57, J Virol, 85, 5949, 10.1128/JVI.02652-10 Boulet, 2008, A combined genotype of KIR3DL1 high expressing alleles A. HLA-B*57 is associated with a reduced risk of HIV infection, AIDS, 22, 1487, 10.1097/QAD.0b013e3282ffde7e Kim, 2005, Licensing of natural killer cells by host major histocompatibility complex class i molecules, Nature, 436, 709, 10.1038/nature03847 Paust, 2011, Natural killer cell memory, Nat Immunol, 12, 500, 10.1038/ni.2032 Nielsen, 2012, Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D LFA-1 and TRAIL and dampened via CD94/NKG2A, PLoS One, 7, e31959, 10.1371/journal.pone.0031959 Kottilil, 2003, Innate immunity in human immunodeficiency virus infection: Effect of viremia on natural killer cell function, J Infect Dis, 187, 38, 10.1086/368222 Reeves, 2010, CD16-natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection, Blood, 115, 4439, 10.1182/blood-2010-01-265595 Costiniuk, 2012, Human immunodeficiency virus and the gastrointestinal immune system: Does highly active antiretroviral therapy restore gut immunity?, Mucosal Immunol, 5, 596, 10.1038/mi.2012.82 Mela, 2007, Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individuals, AIDS, 21, 2177, 10.1097/QAD.0b013e3282f08b72 Dokun, 2001, Specific and nonspecific NK cell activation during virus infection, Nat Immunol, 2, 951, 10.1038/ni714 Fadda, 2010, Peptide antagonism as a mechanism for NK cell activation, Proc Natl Acad Sci U S A, 107, 10160, 10.1073/pnas.0913745107 Tiemessen, 2010, Natural killer cells that respond to human immunodeficiency virus type 1 (HIV-1) peptides are associated with control of HIV-1 infection, J Infect Dis, 202, 1444, 10.1086/656535 Thobakgale, 2012, Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infection, J Virol, 86, 6986, 10.1128/JVI.00569-12 Fadda, 2011, Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules, J Virol, 85, 5970, 10.1128/JVI.00412-11 Brackenridge, 2011, An early HIV mutation within an HLA-B*57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1, J Virol, 85, 5415, 10.1128/JVI.00238-11 Forthal, 2007, Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate, J Immunol, 178, 6596, 10.4049/jimmunol.178.10.6596 Rubnitz, 2010, A pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia, J Clin Oncol, 28, 955, 10.1200/JCO.2009.24.4590 Introna, 2006, Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: An innovative proposal for the treatment of leukemia relapse after cord blood transplantation, Bone Marrow Transplant, 38, 621, 10.1038/sj.bmt.1705503 Rerks-Ngarm, 2009, Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand, N Engl J Med, 361, 2209, 10.1056/NEJMoa0908492 Haynes, 2012, Immune-correlates analysis of an HIV-1 vaccine efficacy trial, N Engl J Med, 366, 1275, 10.1056/NEJMoa1113425 Tomaras, 2013, Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding effector function of IgG, Proc Natl Acad Sci USA, 110, 9019, 10.1073/pnas.1301456110 Madhavi, 2013, Activation of NK cells by HIV-specific ADCC antibodies: Role for granulocytes in expressing HIV-1 peptide epitopes, Hum Vaccin Immunother, 9, 1011, 10.4161/hv.23446 Pena, 2012, Effects on innate immunity of a therapeutic dendritic cell-based vaccine for HIV-1 infection, Viral Immunol, 25, 37, 10.1089/vim.2011.0044